MDxHealth
Startup Vesica Health to Revive MDxHealth Bladder Cancer Assay Boosted by New Clinical Impact Data
Premium
The company is currently fundraising to support a commercial launch within the next few months, aiming to join other competitors in a growing clinical niche.
MDxHealth, University of Oxford to Assess Prostate Test for Predicting Localized Treatment Outcomes
Investigators will work with the company to study the correlation between test results and patient outcomes after localized treatment in a UK cohort.
In Brief This Week: Biocept, Quest, Agilent, MDxHealth, OpGen, More
News items for the week of May 15, 2023.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
William Blair Initiates Coverage of MDxHealth With Outperform Rating
A letter to investors noted the company's dedicated focus on prostate cancer diagnostics, which de-risks the firm's growth outlook and path to profitability.